New Comprehensive Data Platform Accelerates Application Development and Deployment

InterSystemsInterSystems, a global leader in information technology platforms for health, business, and government applications, has introduced the InterSystems IRIS Data Platform®. Built around a high-performance database, InterSystems IRIS is the first and only data platform to provide all of the critical capabilities for rapidly developing data-intensive and mission- critical applications, including advanced data management, interoperability, transaction processing, and analytics.

The platform includes:

  • An advanced multi-model, multi-workload data management engine;
  • Native interoperability;
  • An open analytics platform;
  • Easy deployment in cloud, on-premises or hybrid environments;
  • A unique combination of horizontal and vertical scalability, enabling systems to scale up and down to accommodate rapidly changing workloads and data volumes; and
  • World-class 24/7 customer support

The development and naming of the InterSystems IRIS Data Platform is based on the company's foundational design principles. IRIS stands for Interoperable, Reliable, Intuitive and Scalable - four attributes that InterSystems and its customers believe are required to capitalise on the growing volumes of data entering organisations every day.

According to a recent IDC InfoBrief, commissioned by InterSystems, entitled "Choosing a DBMS to Address the Challenges of the Third Platform," 47 percent of organisations report that untimely data has negatively impacted their business. One of the biggest drivers of untimely data is the reliance on extract, transform, and load (ETL) infrastructures to move data between applications and platforms. By simultaneously performing transactions and analytics in one unified platform, InterSystems IRIS eliminates the need for ETL and provides immediate insights and actions based on the most current data. With native interoperability, the platform integrates seamlessly with existing architectures, systems, and devices accelerating the development and delivery of data-driven applications.

"We created InterSystems IRIS Data Platform with solution creators in mind with all of the critical capabilities for building applications that face the future," said Paul Grabscheid, vice president of Strategic Planning, InterSystems. "The introduction of the IRIS Data Platform represents a significant step forward in the database industry and builds on InterSystems' rich history of technical innovations focused on solving real business problems."

IRIS is the newest member of the InterSystems data platform product family, which also includes the Caché high-performance multi-model database and Ensemble application integration engine. Most customers will be able to upgrade to IRIS Data Platform easily - and for free - should they want to do so.

"Increasingly, enterprises want to be able to perform analytics and transactions on a coherent set of current data, rather than having a specialised, separate database for each operational and analytical workload," said Carl Olofson, research vice president of Data Management Software at IDC.

"InterSystems is leveraging its open architecture to deliver the IRIS Data Platform, which is designed to integrate seamlessly into existing infrastructures and apply best-of-breed technologies to support the widest range of customer environments and application requirements."

The InterSystems IRIS Data Platform will be available worldwide in January 2018.

About InterSystems
InterSystems is the engine behind the world's most important applications. In healthcare, finance, government, and other sectors where lives and livelihoods are at stake, InterSystems is the power behind what mattersTM. Founded in 1978, InterSystems is a privately held company headquartered in Cambridge, Massachusetts (USA), with offices worldwide, and its software products are used daily by millions of people in more than 100 countries.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...